Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

US Patent 12226423 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sustained release drug delivery systems and related methods2025
Sustained release drug delivery systems with reduced impurities and related meth2023
Uses of oxygenated cholesterol sulfates (OCS)2023
Uses of oxygenated cholesterol sulfates (OCS)2023
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2022